Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.

Market Cap 4.91TCr 736.53Cr 658.6Cr 609.32Cr 551.7Cr 1.03TCr 70TCr 1.05TCr 7.33TCr 2.9TCr 37TCr 2.76TCr 2.71TCr 1,16000Cr P/E 2026 *
37.9x
P/E 2027 * 28.4x
Enterprise Value 4.48TCr 670.83Cr 599.86Cr 554.97Cr 502.49Cr 940.46Cr 64TCr 955.87Cr 6.68TCr 2.64TCr 33TCr 2.52TCr 2.46TCr 1,05700Cr EV / Sales 2026 *
5.55x
EV / Sales 2027 * 4.6x
Free-Float
62.13%
Yield 2026 *
0.92%
Yield 2027 * 1.29%
Manager TitleAgeSince
Chief Executive Officer 70 07/10/1998
Chief Executive Officer 49 19/01/2022
President - -
Director TitleAgeSince
Director/Board Member 49 18/07/2011
Chairman 70 07/10/1998
Director/Board Member 65 18/07/2011
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 770.07Cr
+0.45%+1.76%+54.96%+118.11% 1,13500Cr
+0.94%+4.20%+39.86%+75.69% 64TCr
+0.39%+0.46%+25.77%+97.40% 50TCr
+1.43%+4.56%+46.20%+66.91% 38TCr
-3.21%-3.66%+60.72%+35.68% 36TCr
-0.41%+2.23%+22.48%+48.54% 29TCr
+0.23%+3.28%+2.57%+21.89% 27TCr
+1.22%+2.81%+52.40%+63.37% 24TCr
+1.70%+1.60%+31.21%+102.44% 19TCr
Average +0.22%+1.60%+37.35%+70.00% 44.49TCr
Weighted average by Cap. +0.26%+1.63%+41.40%+81.03%

Financials

2026 *2027 *
Net sales 806.26Cr 120.84Cr 108.05Cr 100Cr 91Cr 169.4Cr 11TCr 172.18Cr 1.2TCr 475.84Cr 6.01TCr 453.52Cr 443.83Cr 19TCr 988.7Cr 148.18Cr 132.5Cr 122.59Cr 110.99Cr 207.74Cr 14TCr 211.14Cr 1.48TCr 583.51Cr 7.37TCr 556.15Cr 544.26Cr 23TCr
Net income 132.76Cr 20Cr 18Cr 16Cr 15Cr 28Cr 1.89TCr 28Cr 198.08Cr 78Cr 990.09Cr 75Cr 73Cr 3.13TCr 177.71Cr 27Cr 24Cr 22Cr 20Cr 37Cr 2.53TCr 38Cr 265.15Cr 104.88Cr 1.33TCr 100Cr 98Cr 4.2TCr
Net Debt -438.36Cr -66Cr -59Cr -54Cr -49Cr -92Cr -6.25TCr -94Cr -654.04Cr -258.71Cr -3.27TCr -246.58Cr -241.31Cr -10TCr -366.09Cr -55Cr -49Cr -45Cr -41Cr -77Cr -5.22TCr -78Cr -546.23Cr -216.06Cr -2.73TCr -205.93Cr -201.53Cr -8.64TCr
Logo Asymchem Laboratories (Tianjin) Co., Ltd.
Asymchem Laboratories Tianjin Co Ltd is a China-based company mainly engaged in providing one-stop comprehensive services for pharmaceutical outsourcing. The Company's business includes customized research and development and production of small molecule drugs (CDMO), chemical macromolecule CDMO, clinical research services, formulation CDMO, biological macromolecule CDMO, technology output and synthetic biology. The Company's product categories cover peptides, oligonucleotides, monoclonal antibodies, antibody-conjugated drugs and messenger RNA. The Company mainly conducts its business in domestic and foreign markets.
Employees
10,617
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Asymchem Laboratories (Tianjin) Co., Ltd.